Small-for-size graft syndrome is an inevitable complication in living donor liver transplantation (LDLT). We hypothesized that graft weight (GW) measured after graft procurement is one of the variables predicting postoperative graft function. A total of 138 consecutive recipients of adult-to-adult LDLT between March 1999 and October 2014 were included in this study. We investigated the factors associated with small-for-size-associated graft loss (SAGL) to determine the GW required for each patient. Both preoperatively assessed and postoperatively obtained risk factors for SAGL were analyzed in univariate and multivariate logistic regression analysis. Twelve (8.8%) of the transplant recipients had SAGL. In multivariate logistic regression analyses using preoperatively assessed variables, the preoperative Model for End-Stage Liver Disease (MELD) score (P < 0.001) and actual GW/recipient standard liver volume (SLV) ratio (P 5 0.008) were independent predictors of SAGL. Living donor liver transplantation (LDLT) has been established as a lifesaving treatment for end-stage liver disease (ESLD) and acute liver failure, though it is not considered to be as ideal a treatment as deceased donor liver transplantation due to substantial risk of mortality for living donors.(1-6) Morbidities among living donors are reported to be more frequent in right lobectomy than left lobectomy or left lateral sectionectomy. (7) Many transplant programs use a left lobe graft in LDLT to minimize morbidities in living donors. (8,9) However, despite excellent postoperative results using the left lobe, it is not applicable to a certain group of LDLT candidates. We previously reported that a high preoperative Model for End-Stage Liver Disease (MELD) score (10,11) was associated with postoperative graft failure. (12,13) A Kyushu group also pointed out that ESLD patients with high MELD scores are not suitable candidates for LDLT using a left lobe graft because of poor postoperative prognosis. (9,14) A study in Hong Kong reported that acute or chronic hepatitis B virus (HBV)-infected ESLD patients can be rescued by right lobe with middle hepatic vein (MHV) graft in their LDLT series. (15) Graft volume and recipient prognosis are thought to be correlated, and the minimal graft volume required